Author:
Knutsson Anki,Hsiung Sabrina,Celik Selvi,Rattik Sara,Mattisson Ingrid Yao,Wigren Maria,Scher Howard I.,Nilsson Jan,Hultgårdh-Nilsson Anna
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Van Poppel, H. LHRH agonists versus GnRH antagonists for the treatment of prostate cancer. Belgian J Med Oncol 4, 18–22 (2010).
2. Hakimian, P. et al. Metabolic and cardiovascular effects of androgen deprivation therapy. BJU Int 102, 1509–1514 (2008).
3. Saylor, P. J. & Smith, M. R. Metabolic complications of androgen deprivation therapy for prostate cancer. J Urol 181, 1998–2006 (2009).
4. Basaria, S. Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth. J Androl 29, 534–539 (2008).
5. Nobes, J. P., Langley, S. E. & Laing, R. W. Metabolic syndrome and prostate cancer: a review. Clin Oncol (R Coll Radiol) 21, 183–191 (2009).
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献